.Responsible for a consistent, cross-functional brand strategy shaping and implementation, for all assets having moved from Global to International TA until the handover to IBBI. Will evolve globally created early brand strategies, such as the Integrated Product Strategies (IPS) into a competitive, truly cross-functional launch plan that is fit-for-purpose for core IMI markets and sets a foundation of launch success for Novartis' next blockbusters. (International) - Leads strategic, cross-functional decisions for International and above-brand strategic initiatives, incl. partnerships, policy shaping, and for launched assets, will monitor and respond to major events and competitive landscape developments. (International)Close interaction with core IMI markets, collaboration with MAP and CE&E teams to shape launch deliverables and TA-relevant customer experiences/ journeys and campaigns/ content for major IMI markets, and with respective IM-US counterpart to ensure consistent brand positioning worldwide, leverage learnings and transferable practices. (International) - Leads, manages and develops the overall performance of the TA's current and future product portfolio and deliver sales and profits within agreed budgets. (Region/cluster/country) - Leads and develops a high-performing sales and marketing team and build effective and enduring business relationships with key customers/ stakeholders. (Region/cluster/country)Typically leads a medium to large revenue country organization, covering both sales and marketing activities, with responsibility to drive performance and develop operational strategy for their organization. (Region/cluster/country)About the RoleLocated in Mexico CityMajor accountabilities:Ensures appropriate compliance against company policies and procedures.Responsible for the budget and financial performance of the unit.Develops and implements a regional strategic and operational plan for the TA in close collaboration with local and global teams.Closely follows competitors on the market and provides local marketers with tools to evaluate and counteract competitive entrance on the market.Works with external key opinion leaders in the field to implement projects to optimize patient management and drive the TA forward.Reporting of technical complaints / adverse events / special case scenarios related to Novartis products within 24 hours of receipt - Distribution of marketing samples (where applicable)Key performance indicators:Financial & Business results (Revenue growth, Profitability, Market share) - Maximization of launch readiness and portfolio value/ growth of key assets for major IMI markets.Ensuring the delivery of TA Strategy in major IMI markets